Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity

Autor: Fadini, G. P., Zatti, G., Consoli, A., Bonora, E., Sesti, G., Avogaro, Consoli A, A. DARWIN-T2D. Network., Formoso, G, Antenucci, D, Grossi, G, Pucci, A, Sesti, G, Andreozzi, F, Indrieri, L, Capobianco, G, Gatti, A, Bonadonna, R, Zavaroni, I, Dei Cas, A, Felace, G, Li Volsi, P, Buzzetti, R, Leto, G, D'Angelo, F, Morano, S, Giaccari, A, Sorice, G, Orsi, E, Carlo Bossi, A, Querci, F, Duratorre, E, Malagola, C, Franzetti, I, Silvia Morpurgo, P, Boemi, M, Petrelli, M, Aimaretti, G, Karamouzis, I, Cavalot, F, Saglietti, G, Gruden, G, Devangelio, E, Cazzetta, G, Lamacchia, O, Cervone, S, Frittitta, L, Arena, S, Di Benedetto, A, Piro, S, Giordano, C, Rizzo, M, Chianetta, R, Mannina, C, Solini, A, Natali, A, Anichini, R, Dotta, F, Fattor, B, Avogaro, A, Fadini, Gp, Bonora, E, Cigolini, M, Simioni, N, Frison, V, Poli, M, Lapolla, A, Cristiano Chilelli, N, Author information, Vinci C.

Background Randomized controlled trials (RCTs) in the field of diabetes have limitations inherent to the fact that design, setting, and patient characteristics may be poorly transferrable to clinical practice. Thus, evidence from studies using routin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f7aa263ca27b8ac0678785ddb9d534ad
http://hdl.handle.net/10447/414947